INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
4.400
-0.020 (-0.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
INmune Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 0.04 | 0.16 | 0.37 | 0.18 | 0.01 | - | Upgrade
|
| Revenue Growth (YoY) | -81.25% | -58.56% | 106.63% | 1545.45% | - | - | Upgrade
|
| Gross Profit | 0.04 | 0.16 | 0.37 | 0.18 | 0.01 | - | Upgrade
|
| Selling, General & Admin | 9.77 | 9.62 | 9.26 | 8.79 | 6.32 | 6.02 | Upgrade
|
| Research & Development | 31.82 | 20.27 | 17.07 | 20.54 | 5.92 | 3.28 | Upgrade
|
| Operating Expenses | 41.59 | 29.9 | 26.33 | 29.33 | 12.24 | 9.3 | Upgrade
|
| Operating Income | -41.55 | -29.74 | -25.95 | -29.15 | -12.23 | -9.3 | Upgrade
|
| Interest Expense | -1.74 | -2.28 | -2.01 | - | - | - | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.01 | 2.01 | 0.67 | -1.19 | 0.03 | - | Upgrade
|
| EBT Excluding Unusual Items | -41.27 | -30.01 | -27.3 | -30.34 | -12.2 | -9.22 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.1 | 1.54 | Upgrade
|
| Pretax Income | -41.27 | -30.01 | -27.3 | -30.34 | -12.1 | -7.68 | Upgrade
|
| Net Income | -41.27 | -30.01 | -27.3 | -30.34 | -12.1 | -7.68 | Upgrade
|
| Net Income to Common | -41.27 | -30.01 | -27.3 | -30.34 | -12.1 | -7.68 | Upgrade
|
| Shares Outstanding (Basic) | 19 | 18 | 18 | 16 | 12 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 18 | 18 | 16 | 12 | 10 | Upgrade
|
| Shares Change (YoY) | 5.16% | 0.30% | 11.14% | 34.55% | 16.70% | 18.39% | Upgrade
|
| EPS (Basic) | -2.19 | -1.67 | -1.52 | -1.88 | -1.01 | -0.75 | Upgrade
|
| EPS (Diluted) | -2.19 | -1.67 | -1.52 | -1.88 | -1.01 | -0.75 | Upgrade
|
| Free Cash Flow | -25.75 | -11.98 | -22.69 | -28.5 | -8.94 | -5.38 | Upgrade
|
| Free Cash Flow Per Share | -1.36 | -0.67 | -1.27 | -1.77 | -0.75 | -0.52 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | Upgrade
|
| Operating Margin | -98921.43% | -19187.74% | -6938.77% | -16106.63% | -111163.64% | - | Upgrade
|
| Profit Margin | -98266.67% | -19360.00% | -7299.20% | -16762.43% | -109990.91% | - | Upgrade
|
| Free Cash Flow Margin | -61307.14% | -7729.03% | -6065.78% | -15748.07% | -81300.00% | - | Upgrade
|
| EBIT | -41.55 | -29.74 | -25.95 | -29.15 | -12.23 | -9.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.